Back to search results

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Penile Squamous Cell Carcinoma · Stage III Penile Cancer AJCC v8 · Stage IV Penile Cancer AJCC v8 · Unresectable Penile Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Cassandra N. Moore, M.D.)

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Winston W. Tan, M.D.)

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Lance C. Pagliaro, M.D.)
Study leads

  • Lance C. Pagliaro, M.D.

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)